nodes	percent_of_prediction	percent_of_DWPC	metapath
Avanafil—CYP3A4—bone cancer	0.924	1	CbGaD
Avanafil—Balanitis—Epirubicin—bone cancer	0.00333	0.0436	CcSEcCtD
Avanafil—Balanitis—Doxorubicin—bone cancer	0.00308	0.0404	CcSEcCtD
Avanafil—Dyspnoea exertional—Epirubicin—bone cancer	0.00181	0.0237	CcSEcCtD
Avanafil—Dyspnoea exertional—Doxorubicin—bone cancer	0.00168	0.0219	CcSEcCtD
Avanafil—Rhinorrhoea—Cisplatin—bone cancer	0.00131	0.0172	CcSEcCtD
Avanafil—Infection—Carboplatin—bone cancer	0.00129	0.0169	CcSEcCtD
Avanafil—Wheezing—Cisplatin—bone cancer	0.00103	0.0135	CcSEcCtD
Avanafil—Body temperature increased—Carboplatin—bone cancer	0.00102	0.0134	CcSEcCtD
Avanafil—Deep vein thrombosis—Methotrexate—bone cancer	0.000961	0.0126	CcSEcCtD
Avanafil—Nasal congestion—Cisplatin—bone cancer	0.000849	0.0111	CcSEcCtD
Avanafil—Blood creatinine increased—Cisplatin—bone cancer	0.000724	0.00948	CcSEcCtD
Avanafil—Breast disorder—Cisplatin—bone cancer	0.000699	0.00915	CcSEcCtD
Avanafil—Nasopharyngitis—Cisplatin—bone cancer	0.000691	0.00905	CcSEcCtD
Avanafil—Abdominal discomfort—Cisplatin—bone cancer	0.000641	0.00839	CcSEcCtD
Avanafil—Hepatic enzyme increased—Methotrexate—bone cancer	0.000618	0.00809	CcSEcCtD
Avanafil—Blood bilirubin increased—Epirubicin—bone cancer	0.000578	0.00757	CcSEcCtD
Avanafil—Musculoskeletal pain—Epirubicin—bone cancer	0.000554	0.00725	CcSEcCtD
Avanafil—Blood bilirubin increased—Doxorubicin—bone cancer	0.000535	0.00701	CcSEcCtD
Avanafil—Influenza like illness—Epirubicin—bone cancer	0.000531	0.00696	CcSEcCtD
Avanafil—Urinary tract disorder—Cisplatin—bone cancer	0.000528	0.00692	CcSEcCtD
Avanafil—Connective tissue disorder—Cisplatin—bone cancer	0.000526	0.00688	CcSEcCtD
Avanafil—Urethral disorder—Cisplatin—bone cancer	0.000524	0.00686	CcSEcCtD
Avanafil—Musculoskeletal pain—Doxorubicin—bone cancer	0.000512	0.00671	CcSEcCtD
Avanafil—Eye disorder—Cisplatin—bone cancer	0.0005	0.00654	CcSEcCtD
Avanafil—Flushing—Cisplatin—bone cancer	0.000496	0.0065	CcSEcCtD
Avanafil—Cardiac disorder—Cisplatin—bone cancer	0.000496	0.0065	CcSEcCtD
Avanafil—Influenza like illness—Doxorubicin—bone cancer	0.000492	0.00644	CcSEcCtD
Avanafil—Diabetes mellitus—Methotrexate—bone cancer	0.000488	0.00639	CcSEcCtD
Avanafil—Immune system disorder—Cisplatin—bone cancer	0.000483	0.00633	CcSEcCtD
Avanafil—Mediastinal disorder—Cisplatin—bone cancer	0.000482	0.00631	CcSEcCtD
Avanafil—Malnutrition—Cisplatin—bone cancer	0.000466	0.0061	CcSEcCtD
Avanafil—Diabetes mellitus—Epirubicin—bone cancer	0.000457	0.00598	CcSEcCtD
Avanafil—Muscle spasms—Cisplatin—bone cancer	0.000448	0.00586	CcSEcCtD
Avanafil—Vision blurred—Cisplatin—bone cancer	0.000439	0.00575	CcSEcCtD
Avanafil—Hot flush—Epirubicin—bone cancer	0.000424	0.00556	CcSEcCtD
Avanafil—Diabetes mellitus—Doxorubicin—bone cancer	0.000422	0.00553	CcSEcCtD
Avanafil—Menopausal symptoms—Epirubicin—bone cancer	0.000421	0.00551	CcSEcCtD
Avanafil—Hypoglycaemia—Epirubicin—bone cancer	0.000407	0.00533	CcSEcCtD
Avanafil—Pain in extremity—Epirubicin—bone cancer	0.000397	0.0052	CcSEcCtD
Avanafil—Myalgia—Cisplatin—bone cancer	0.000396	0.00519	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000394	0.00515	CcSEcCtD
Avanafil—Hot flush—Doxorubicin—bone cancer	0.000393	0.00514	CcSEcCtD
Avanafil—Menopausal symptoms—Doxorubicin—bone cancer	0.000389	0.0051	CcSEcCtD
Avanafil—Breast disorder—Methotrexate—bone cancer	0.000383	0.00502	CcSEcCtD
Avanafil—Infection—Cisplatin—bone cancer	0.000378	0.00494	CcSEcCtD
Avanafil—Hypoglycaemia—Doxorubicin—bone cancer	0.000376	0.00493	CcSEcCtD
Avanafil—Nervous system disorder—Cisplatin—bone cancer	0.000373	0.00488	CcSEcCtD
Avanafil—Blood creatinine increased—Epirubicin—bone cancer	0.000372	0.00487	CcSEcCtD
Avanafil—Tachycardia—Cisplatin—bone cancer	0.000371	0.00486	CcSEcCtD
Avanafil—Skin disorder—Cisplatin—bone cancer	0.000369	0.00483	CcSEcCtD
Avanafil—Pain in extremity—Doxorubicin—bone cancer	0.000367	0.00481	CcSEcCtD
Avanafil—Breast disorder—Epirubicin—bone cancer	0.000359	0.0047	CcSEcCtD
Avanafil—Hypotension—Cisplatin—bone cancer	0.000355	0.00465	CcSEcCtD
Avanafil—Nasopharyngitis—Epirubicin—bone cancer	0.000355	0.00465	CcSEcCtD
Avanafil—Abdominal discomfort—Methotrexate—bone cancer	0.000352	0.0046	CcSEcCtD
Avanafil—Gastritis—Epirubicin—bone cancer	0.000351	0.0046	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Epirubicin—bone cancer	0.00035	0.00459	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000346	0.00453	CcSEcCtD
Avanafil—Blood creatinine increased—Doxorubicin—bone cancer	0.000344	0.00451	CcSEcCtD
Avanafil—Influenza—Epirubicin—bone cancer	0.000343	0.00449	CcSEcCtD
Avanafil—Upper respiratory tract infection—Methotrexate—bone cancer	0.000341	0.00446	CcSEcCtD
Avanafil—Angina pectoris—Epirubicin—bone cancer	0.000334	0.00438	CcSEcCtD
Avanafil—Breast disorder—Doxorubicin—bone cancer	0.000332	0.00435	CcSEcCtD
Avanafil—Bronchitis—Epirubicin—bone cancer	0.00033	0.00432	CcSEcCtD
Avanafil—Nasopharyngitis—Doxorubicin—bone cancer	0.000329	0.0043	CcSEcCtD
Avanafil—Gastrointestinal disorder—Cisplatin—bone cancer	0.000328	0.0043	CcSEcCtD
Avanafil—Infestation NOS—Methotrexate—bone cancer	0.000327	0.00428	CcSEcCtD
Avanafil—Infestation—Methotrexate—bone cancer	0.000327	0.00428	CcSEcCtD
Avanafil—Gastritis—Doxorubicin—bone cancer	0.000325	0.00426	CcSEcCtD
Avanafil—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000324	0.00424	CcSEcCtD
Avanafil—Upper respiratory tract infection—Epirubicin—bone cancer	0.000319	0.00418	CcSEcCtD
Avanafil—Influenza—Doxorubicin—bone cancer	0.000318	0.00416	CcSEcCtD
Avanafil—Pollakiuria—Epirubicin—bone cancer	0.000317	0.00415	CcSEcCtD
Avanafil—Weight increased—Epirubicin—bone cancer	0.000312	0.00409	CcSEcCtD
Avanafil—Haematuria—Methotrexate—bone cancer	0.000312	0.00408	CcSEcCtD
Avanafil—Angina pectoris—Doxorubicin—bone cancer	0.000309	0.00405	CcSEcCtD
Avanafil—Epistaxis—Methotrexate—bone cancer	0.000308	0.00404	CcSEcCtD
Avanafil—Infestation NOS—Epirubicin—bone cancer	0.000306	0.00401	CcSEcCtD
Avanafil—Infestation—Epirubicin—bone cancer	0.000306	0.00401	CcSEcCtD
Avanafil—Bronchitis—Doxorubicin—bone cancer	0.000305	0.004	CcSEcCtD
Avanafil—Body temperature increased—Cisplatin—bone cancer	0.0003	0.00393	CcSEcCtD
Avanafil—Urinary tract infection—Epirubicin—bone cancer	0.000297	0.00389	CcSEcCtD
Avanafil—Upper respiratory tract infection—Doxorubicin—bone cancer	0.000295	0.00386	CcSEcCtD
Avanafil—Pollakiuria—Doxorubicin—bone cancer	0.000293	0.00384	CcSEcCtD
Avanafil—Haematuria—Epirubicin—bone cancer	0.000292	0.00382	CcSEcCtD
Avanafil—Urinary tract disorder—Methotrexate—bone cancer	0.00029	0.0038	CcSEcCtD
Avanafil—Weight increased—Doxorubicin—bone cancer	0.000289	0.00378	CcSEcCtD
Avanafil—Epistaxis—Epirubicin—bone cancer	0.000289	0.00378	CcSEcCtD
Avanafil—Urethral disorder—Methotrexate—bone cancer	0.000288	0.00377	CcSEcCtD
Avanafil—Sinusitis—Epirubicin—bone cancer	0.000287	0.00376	CcSEcCtD
Avanafil—Infestation NOS—Doxorubicin—bone cancer	0.000283	0.00371	CcSEcCtD
Avanafil—Infestation—Doxorubicin—bone cancer	0.000283	0.00371	CcSEcCtD
Avanafil—Urinary tract infection—Doxorubicin—bone cancer	0.000275	0.0036	CcSEcCtD
Avanafil—Eye disorder—Methotrexate—bone cancer	0.000274	0.00359	CcSEcCtD
Avanafil—Asthenia—Cisplatin—bone cancer	0.000273	0.00357	CcSEcCtD
Avanafil—Cardiac disorder—Methotrexate—bone cancer	0.000272	0.00357	CcSEcCtD
Avanafil—Urinary tract disorder—Epirubicin—bone cancer	0.000271	0.00355	CcSEcCtD
Avanafil—Oedema peripheral—Epirubicin—bone cancer	0.000271	0.00354	CcSEcCtD
Avanafil—Haematuria—Doxorubicin—bone cancer	0.00027	0.00353	CcSEcCtD
Avanafil—Connective tissue disorder—Epirubicin—bone cancer	0.00027	0.00353	CcSEcCtD
Avanafil—Urethral disorder—Epirubicin—bone cancer	0.000269	0.00353	CcSEcCtD
Avanafil—Epistaxis—Doxorubicin—bone cancer	0.000267	0.0035	CcSEcCtD
Avanafil—Angiopathy—Methotrexate—bone cancer	0.000266	0.00349	CcSEcCtD
Avanafil—Sinusitis—Doxorubicin—bone cancer	0.000266	0.00348	CcSEcCtD
Avanafil—Immune system disorder—Methotrexate—bone cancer	0.000265	0.00347	CcSEcCtD
Avanafil—Mediastinal disorder—Methotrexate—bone cancer	0.000265	0.00346	CcSEcCtD
Avanafil—Diarrhoea—Cisplatin—bone cancer	0.00026	0.0034	CcSEcCtD
Avanafil—Mental disorder—Methotrexate—bone cancer	0.000257	0.00337	CcSEcCtD
Avanafil—Eye disorder—Epirubicin—bone cancer	0.000257	0.00336	CcSEcCtD
Avanafil—Malnutrition—Methotrexate—bone cancer	0.000256	0.00335	CcSEcCtD
Avanafil—Flushing—Epirubicin—bone cancer	0.000255	0.00334	CcSEcCtD
Avanafil—Cardiac disorder—Epirubicin—bone cancer	0.000255	0.00334	CcSEcCtD
Avanafil—Urinary tract disorder—Doxorubicin—bone cancer	0.000251	0.00329	CcSEcCtD
Avanafil—Oedema peripheral—Doxorubicin—bone cancer	0.00025	0.00328	CcSEcCtD
Avanafil—Connective tissue disorder—Doxorubicin—bone cancer	0.00025	0.00327	CcSEcCtD
Avanafil—Angiopathy—Epirubicin—bone cancer	0.000249	0.00326	CcSEcCtD
Avanafil—Urethral disorder—Doxorubicin—bone cancer	0.000249	0.00326	CcSEcCtD
Avanafil—Immune system disorder—Epirubicin—bone cancer	0.000248	0.00325	CcSEcCtD
Avanafil—Mediastinal disorder—Epirubicin—bone cancer	0.000248	0.00324	CcSEcCtD
Avanafil—Back pain—Methotrexate—bone cancer	0.000247	0.00324	CcSEcCtD
Avanafil—Vomiting—Cisplatin—bone cancer	0.000242	0.00316	CcSEcCtD
Avanafil—Vision blurred—Methotrexate—bone cancer	0.000241	0.00315	CcSEcCtD
Avanafil—Mental disorder—Epirubicin—bone cancer	0.000241	0.00315	CcSEcCtD
Avanafil—Rash—Cisplatin—bone cancer	0.00024	0.00314	CcSEcCtD
Avanafil—Dermatitis—Cisplatin—bone cancer	0.000239	0.00313	CcSEcCtD
Avanafil—Malnutrition—Epirubicin—bone cancer	0.000239	0.00313	CcSEcCtD
Avanafil—Eye disorder—Doxorubicin—bone cancer	0.000238	0.00311	CcSEcCtD
Avanafil—Flushing—Doxorubicin—bone cancer	0.000236	0.00309	CcSEcCtD
Avanafil—Cardiac disorder—Doxorubicin—bone cancer	0.000236	0.00309	CcSEcCtD
Avanafil—Back pain—Epirubicin—bone cancer	0.000231	0.00303	CcSEcCtD
Avanafil—Angiopathy—Doxorubicin—bone cancer	0.000231	0.00302	CcSEcCtD
Avanafil—Muscle spasms—Epirubicin—bone cancer	0.00023	0.00301	CcSEcCtD
Avanafil—Immune system disorder—Doxorubicin—bone cancer	0.00023	0.00301	CcSEcCtD
Avanafil—Vertigo—Methotrexate—bone cancer	0.00023	0.00301	CcSEcCtD
Avanafil—Mediastinal disorder—Doxorubicin—bone cancer	0.000229	0.003	CcSEcCtD
Avanafil—Nausea—Cisplatin—bone cancer	0.000226	0.00296	CcSEcCtD
Avanafil—Vision blurred—Epirubicin—bone cancer	0.000225	0.00295	CcSEcCtD
Avanafil—Cough—Methotrexate—bone cancer	0.000223	0.00292	CcSEcCtD
Avanafil—Mental disorder—Doxorubicin—bone cancer	0.000223	0.00292	CcSEcCtD
Avanafil—Malnutrition—Doxorubicin—bone cancer	0.000221	0.0029	CcSEcCtD
Avanafil—Agitation—Epirubicin—bone cancer	0.00022	0.00288	CcSEcCtD
Avanafil—Chest pain—Methotrexate—bone cancer	0.000218	0.00285	CcSEcCtD
Avanafil—Arthralgia—Methotrexate—bone cancer	0.000218	0.00285	CcSEcCtD
Avanafil—Myalgia—Methotrexate—bone cancer	0.000218	0.00285	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000216	0.00283	CcSEcCtD
Avanafil—Vertigo—Epirubicin—bone cancer	0.000215	0.00281	CcSEcCtD
Avanafil—Back pain—Doxorubicin—bone cancer	0.000214	0.0028	CcSEcCtD
Avanafil—Muscle spasms—Doxorubicin—bone cancer	0.000213	0.00279	CcSEcCtD
Avanafil—Palpitations—Epirubicin—bone cancer	0.000211	0.00277	CcSEcCtD
Avanafil—Cough—Epirubicin—bone cancer	0.000209	0.00273	CcSEcCtD
Avanafil—Vision blurred—Doxorubicin—bone cancer	0.000209	0.00273	CcSEcCtD
Avanafil—Infection—Methotrexate—bone cancer	0.000207	0.00271	CcSEcCtD
Avanafil—Hypertension—Epirubicin—bone cancer	0.000206	0.0027	CcSEcCtD
Avanafil—Nervous system disorder—Methotrexate—bone cancer	0.000205	0.00268	CcSEcCtD
Avanafil—Arthralgia—Epirubicin—bone cancer	0.000204	0.00267	CcSEcCtD
Avanafil—Chest pain—Epirubicin—bone cancer	0.000204	0.00267	CcSEcCtD
Avanafil—Myalgia—Epirubicin—bone cancer	0.000204	0.00267	CcSEcCtD
Avanafil—Agitation—Doxorubicin—bone cancer	0.000203	0.00266	CcSEcCtD
Avanafil—Skin disorder—Methotrexate—bone cancer	0.000203	0.00265	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000202	0.00265	CcSEcCtD
Avanafil—Dry mouth—Epirubicin—bone cancer	0.000199	0.00261	CcSEcCtD
Avanafil—Vertigo—Doxorubicin—bone cancer	0.000199	0.0026	CcSEcCtD
Avanafil—Palpitations—Doxorubicin—bone cancer	0.000196	0.00256	CcSEcCtD
Avanafil—Hypotension—Methotrexate—bone cancer	0.000195	0.00255	CcSEcCtD
Avanafil—Infection—Epirubicin—bone cancer	0.000194	0.00254	CcSEcCtD
Avanafil—Cough—Doxorubicin—bone cancer	0.000193	0.00253	CcSEcCtD
Avanafil—Nervous system disorder—Epirubicin—bone cancer	0.000191	0.00251	CcSEcCtD
Avanafil—Hypertension—Doxorubicin—bone cancer	0.000191	0.0025	CcSEcCtD
Avanafil—Tachycardia—Epirubicin—bone cancer	0.00019	0.00249	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Methotrexate—bone cancer	0.00019	0.00249	CcSEcCtD
Avanafil—Skin disorder—Epirubicin—bone cancer	0.00019	0.00248	CcSEcCtD
Avanafil—Insomnia—Methotrexate—bone cancer	0.000189	0.00247	CcSEcCtD
Avanafil—Myalgia—Doxorubicin—bone cancer	0.000188	0.00247	CcSEcCtD
Avanafil—Chest pain—Doxorubicin—bone cancer	0.000188	0.00247	CcSEcCtD
Avanafil—Arthralgia—Doxorubicin—bone cancer	0.000188	0.00247	CcSEcCtD
Avanafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000187	0.00245	CcSEcCtD
Avanafil—Somnolence—Methotrexate—bone cancer	0.000185	0.00243	CcSEcCtD
Avanafil—Dry mouth—Doxorubicin—bone cancer	0.000184	0.00241	CcSEcCtD
Avanafil—Dyspepsia—Methotrexate—bone cancer	0.000184	0.0024	CcSEcCtD
Avanafil—Hypotension—Epirubicin—bone cancer	0.000182	0.00239	CcSEcCtD
Avanafil—Gastrointestinal disorder—Methotrexate—bone cancer	0.00018	0.00236	CcSEcCtD
Avanafil—Fatigue—Methotrexate—bone cancer	0.00018	0.00235	CcSEcCtD
Avanafil—Infection—Doxorubicin—bone cancer	0.000179	0.00235	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000178	0.00233	CcSEcCtD
Avanafil—Nervous system disorder—Doxorubicin—bone cancer	0.000177	0.00232	CcSEcCtD
Avanafil—Insomnia—Epirubicin—bone cancer	0.000177	0.00231	CcSEcCtD
Avanafil—Tachycardia—Doxorubicin—bone cancer	0.000176	0.00231	CcSEcCtD
Avanafil—Skin disorder—Doxorubicin—bone cancer	0.000175	0.0023	CcSEcCtD
Avanafil—Somnolence—Epirubicin—bone cancer	0.000173	0.00227	CcSEcCtD
Avanafil—Dyspepsia—Epirubicin—bone cancer	0.000172	0.00225	CcSEcCtD
Avanafil—Hypotension—Doxorubicin—bone cancer	0.000169	0.00221	CcSEcCtD
Avanafil—Gastrointestinal disorder—Epirubicin—bone cancer	0.000168	0.00221	CcSEcCtD
Avanafil—Fatigue—Epirubicin—bone cancer	0.000168	0.0022	CcSEcCtD
Avanafil—Constipation—Epirubicin—bone cancer	0.000167	0.00218	CcSEcCtD
Avanafil—Body temperature increased—Methotrexate—bone cancer	0.000165	0.00216	CcSEcCtD
Avanafil—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000165	0.00215	CcSEcCtD
Avanafil—Insomnia—Doxorubicin—bone cancer	0.000163	0.00214	CcSEcCtD
Avanafil—Somnolence—Doxorubicin—bone cancer	0.000161	0.0021	CcSEcCtD
Avanafil—Dyspepsia—Doxorubicin—bone cancer	0.000159	0.00208	CcSEcCtD
Avanafil—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000156	0.00204	CcSEcCtD
Avanafil—Fatigue—Doxorubicin—bone cancer	0.000156	0.00204	CcSEcCtD
Avanafil—Constipation—Doxorubicin—bone cancer	0.000154	0.00202	CcSEcCtD
Avanafil—Body temperature increased—Epirubicin—bone cancer	0.000154	0.00202	CcSEcCtD
Avanafil—Asthenia—Methotrexate—bone cancer	0.00015	0.00196	CcSEcCtD
Avanafil—Pruritus—Methotrexate—bone cancer	0.000148	0.00193	CcSEcCtD
Avanafil—Body temperature increased—Doxorubicin—bone cancer	0.000143	0.00187	CcSEcCtD
Avanafil—Diarrhoea—Methotrexate—bone cancer	0.000143	0.00187	CcSEcCtD
Avanafil—Asthenia—Epirubicin—bone cancer	0.00014	0.00183	CcSEcCtD
Avanafil—Pruritus—Epirubicin—bone cancer	0.000138	0.00181	CcSEcCtD
Avanafil—Dizziness—Methotrexate—bone cancer	0.000138	0.00181	CcSEcCtD
Avanafil—Diarrhoea—Epirubicin—bone cancer	0.000134	0.00175	CcSEcCtD
Avanafil—Vomiting—Methotrexate—bone cancer	0.000133	0.00174	CcSEcCtD
Avanafil—Rash—Methotrexate—bone cancer	0.000131	0.00172	CcSEcCtD
Avanafil—Dermatitis—Methotrexate—bone cancer	0.000131	0.00172	CcSEcCtD
Avanafil—Headache—Methotrexate—bone cancer	0.000131	0.00171	CcSEcCtD
Avanafil—Asthenia—Doxorubicin—bone cancer	0.00013	0.0017	CcSEcCtD
Avanafil—Dizziness—Epirubicin—bone cancer	0.000129	0.00169	CcSEcCtD
Avanafil—Pruritus—Doxorubicin—bone cancer	0.000128	0.00167	CcSEcCtD
Avanafil—Vomiting—Epirubicin—bone cancer	0.000124	0.00162	CcSEcCtD
Avanafil—Nausea—Methotrexate—bone cancer	0.000124	0.00162	CcSEcCtD
Avanafil—Diarrhoea—Doxorubicin—bone cancer	0.000124	0.00162	CcSEcCtD
Avanafil—Rash—Epirubicin—bone cancer	0.000123	0.00161	CcSEcCtD
Avanafil—Dermatitis—Epirubicin—bone cancer	0.000123	0.00161	CcSEcCtD
Avanafil—Headache—Epirubicin—bone cancer	0.000122	0.0016	CcSEcCtD
Avanafil—Dizziness—Doxorubicin—bone cancer	0.000119	0.00156	CcSEcCtD
Avanafil—Nausea—Epirubicin—bone cancer	0.000116	0.00152	CcSEcCtD
Avanafil—Vomiting—Doxorubicin—bone cancer	0.000115	0.0015	CcSEcCtD
Avanafil—Rash—Doxorubicin—bone cancer	0.000114	0.00149	CcSEcCtD
Avanafil—Dermatitis—Doxorubicin—bone cancer	0.000114	0.00149	CcSEcCtD
Avanafil—Headache—Doxorubicin—bone cancer	0.000113	0.00148	CcSEcCtD
Avanafil—Nausea—Doxorubicin—bone cancer	0.000107	0.0014	CcSEcCtD
